JERSEY CITY, N.J., July 25, 2017 /PRNewswire/ -- MT Pharma America, Inc. today announced that healthcare providers (HCPs) now can begin the insurance benefits investigation process for their patients ...

BANNOCKBURN, Ill.--(BUSINESS WIRE)--Option Care Enterprises, Inc., the nation’s largest independent provider of home and alternate treatment site infusion services, has signed an agreement to become a ...

JERSEY CITY, N.J., May 5, 2020 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today reported that more than 5,000 people with amyotrophic lateral sclerosis (ALS) have received the ...

Five years after the FDA approved Mitsubishi Tanabe's Radicava as an infused treatment for Lou Gehrig's disease, the U.S. regulator has signed off on its oral version. () Hour-long infusions at a ...

Mitsubishi Tanabe Pharma America's Radicava is the second-ever FDA-approved ALS med. () How do you get 100% of the payers you approach to cover a pricey new med? Launch the first novel treatment in ...

SACRAMENTO (CBS13) — For the first time in more than 20 years, a new drug to treat ALS is now available in the United States. The drug Radicava was approved by the FDA and has proved to be effective ...

(NEW YORK) -- It is the first new drug for amyotrophic lateral sclerosis (ALS) in 22 years to become available in the United States. Called edaravone -- brand name Radicava -- its FDA approval this ...

Eli Lilly’s Mounjaro (tirzepatide; injection) has been approved for improving blood sugar control in adults with type 2 diabetes, in combination with diet and exercise. Mounjaro is a dual agonist for ...

JERSEY CITY, N.J., Jan. 14, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced upgrades to its out-of-pocket assistance program that aim to provide enhanced support for ...

Every 90 minutes in the United States, someone is diagnosed with ALS (Amyotrophic Lateral Sclerosis), and every 90 minutes someone loses the battle against the fatal disease. ALS, also commonly known ...